ENHERTU® EU Approval: First HER2 Therapy for HR+ Metastatic BC
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of...
Tag : Medicinal Products
Neurim Gets EU Approval for Slenyto® in ADHD Pediatric Insomnia
Neurim Pharmaceuticals (“Neurim”) announces that the European Commission has approved the extension of the indication to include the treatment of insomnia in children with attention deficit...